Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Andrea, Treszl"'
Autor:
Gabor Halmos, Nikoletta Dobos, Lóránt Székvölgyi, Zita Steiber, Gabor Olah, Kata Hegyi, Andrea Treszl, Andrew V. Schally, Klara Fodor, Gábor Méhes, Éva Sipos
Publikováno v:
Oncology Reports
Uveal melanoma (UM) is the most common primary intraocular malignancy with a very poor prognosis. The most frequent chromosome aberration in UM is the monosomy of chromosome 3. Previously, we demonstrated that ~50% of UMs express type-I receptor for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40408b734eb08e3ac810e035f8ca2809
Autor:
János Nagy, László Bognár, Normann L. Block, Laura Vízkeleti, Aliz Juhász, Andrea Treszl, Almos Klekner, Géza Mezey, Margit Balázs, Gabor Halmos, Andrew V. Schally
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 140:1641-1649
Glioblastoma (GB) is the most frequent brain tumor. Despite recent improvement in therapeutic strategies, the prognosis of GB remains poor. Growth hormone-releasing hormone (GHRH) may act as a growth factor; antagonists of GHRH have been successfully
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319f051015065277a2358b4ca2eaec70
https://doi.org/10.1007/s00432-014-1716-1
https://doi.org/10.1007/s00432-014-1716-1
Autor:
Andrew V. Schally, Stefan R. Bornstein, Andrea Treszl, A Erler, Louise Young, Graeme Eisenhofer, Linda Gebauer, S Petersenn, Monika Ehrhart-Bornstein, Christian G. Ziegler, L M Fishman, J B Engel, Jacqueline T. Brown, Holger S. Willenberg
Publikováno v:
Proceedings of the National Academy of Sciences. 106:15879-15884
Peptide analogues targeting various neuropeptide receptors have been used effectively in cancer therapy. A hallmark of adrenocortical tumor formation is the aberrant expression of peptide receptors relating to uncontrolled cell proliferation and horm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::265b1267126f7f6ac646de6093c74cd5
https://doi.org/10.1073/pnas.0907843106
https://doi.org/10.1073/pnas.0907843106
Autor:
István Juhász, Eniko Toth, Márk Barok, Zsuzsa Rákosy, John W. Park, Péter Nagy, György Vereb, Margit Balázs, Jorma Isola, János Szöllosi, Andrea Treszl
Publikováno v:
Cancer Letters. 260:198-208
We have recently shown that despite of the fact that the ErbB2-positive JIMT-1 human breast cancer cells intrinsically resistant to trastuzumab in vitro, trastuzumab inhibited the outgrowth of early phase JIMT-1 xenografts in SCID mice via antibody-d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74f5f0b812cdb9a8e6e8602177ad4c5f
https://doi.org/10.1016/j.canlet.2007.10.043
https://doi.org/10.1016/j.canlet.2007.10.043
Autor:
Toshiyuki Shibata, Róza Ádány, Makoto Toida, Tomomi Yamashita, Zsuzsa Rákosy, Keizo Kato, Margit Balázs, Andrea Treszl, Sojiro Mori, Tatsuhiko Suwa, Toshiaki Matsui, Daijiro Hatakeyama, Yutaka Yamazaki, Hiroki Makita
Publikováno v:
Cancer Genetics and Cytogenetics. 159:99-104
In order to characterize the chromosomal alterations in ameloblastomas, a combination of comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) techniques was performed on 9 tumors. Chromosomal alterations including a g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be104aaffeb22689fab73618ce8492d6
https://doi.org/10.1016/j.cancergencyto.2004.10.004
https://doi.org/10.1016/j.cancergencyto.2004.10.004
Autor:
László Kardos, Ágnes Bégány, Katalin Gilde, Margit Balázs, Róza Ádány, Zsuzsa Rákosy, Andrea Treszl
Publikováno v:
Cytometry Part B: Clinical Cytometry. :37-46
Background Amplification of c-myc is a common genetic alteration and associated with a poor prognosis in a variety of cancers. Extra copies of the gene have been found in large numbers of melanoma metastases, but only few primary tumours have been st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c85028fda720203f70b37d4876c2c80a
https://doi.org/10.1002/cyto.b.20016
https://doi.org/10.1002/cyto.b.20016
Publikováno v:
Cytometry. 46:222-232
Characteristic genetic changes underlying the metastatic progression of malignant melanoma is incompletely understood. The goal of our study was to explore specific chromosomal alterations associated with the aggressive behavior of this neoplasm. Com
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::19fae7a99c60e7a29b4e81f2d7bdd9a7
https://doi.org/10.1002/cyto.1131
https://doi.org/10.1002/cyto.1131
Publikováno v:
Acta Ophthalmologica. 91
Purpose Uveal melanoma is a rare but very aggressive malignancy. Independently of the currently available therapies, 50 % of uveal melanoma patients will develop metastasis and the average survival time of these patients is only 2-8 months. Genetic a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cdc2166b3c893373beb0849e8b20ba1
https://doi.org/10.1111/j.1755-3768.2013.s092.x
https://doi.org/10.1111/j.1755-3768.2013.s092.x
Autor:
Marta Zarandi, Olaf Ortmann, Andrew V. Schally, Andrea Treszl, F. Hohla, Stefan Buchholz, Stephan Seitz, JB Engel, Luca Szalontay, Ferenc G. Rick
Publikováno v:
Oncology reports. 30(1)
In preclinical studies, antagonists of growth hormone-releasing hormone (GHRH) have demonstrated inhibitory effects on the growth of various types of cancers expressing the pituitary type of GHRH receptors (pGHRH-R) and/or its active splice variant 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efafda8857ccac6e290f7364d505f789
https://pubmed.ncbi.nlm.nih.gov/23624870
https://pubmed.ncbi.nlm.nih.gov/23624870
Autor:
Norman L. Block, Klara Fodor, Gabor Olah, Balazs Dezso, Andrea Treszl, Bernadett Rozsa, Armin Buglyo, János Gardi, Zita Steiber, Andrew V. Schally, Gabor Halmos, András Berta
Publikováno v:
Scopus-Elsevier
Oncotarget
Oncotarget
Uveal melanoma is the most common primary intraocular malignancy in adults, with a very high mortality rate due to frequent liver metastases. Consequently, the therapy of uveal melanoma remains a major clinical challenge and new treatment approaches
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cbd30280889a9f62805850c717e7bc